IDEAYA Biosciences Statistics
Want to see IDYA full AI Analyst Report?
IDEAYA Biosciences (IDYA) Stock Statistics & Valuation Metrics
Total Valuation
IDEAYA Biosciences has a market cap or net worth of $3.07B. The enterprise value is $3.15B.
- Market Cap
- $3.07B
- Enterprise Value
- $3.15B
Share Statistics
IDEAYA Biosciences has 96,694,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 96,694,570
- Owned by Insiders
- 0.81%
- Owned by Institutions
- 53.36%
Financial Efficiency
IDEAYA Biosciences’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -15.16%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.10
- Return on Invested Capital (ROIC)
- -15.16%
- Return on Capital Employed (ROCE)
- -0.15
- Revenue Per Employee
- 1.51M
- Profits Per Employee
- -784.12K
- Employee Count
- 145
- Asset Turnover
- 0.20
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of IDEAYA Biosciences is -7.29. IDEAYA Biosciences’s PEG ratio is 0.06.
- PE Ratio
- -7.29
- PS Ratio
- 86.58
- PB Ratio
- 3.08
- Price to FCF
- -9.04
- Price to Operating Cash Flow
- -9.70
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, IDEAYA Biosciences had revenue of 218.71M and earned -113.70M in profits. Earnings per share was -1.28.
- Revenue
- 218.71M
- Gross Profit
- -95.99M
- Operating Income
- -159.31M
- Pretax Income
- -113.70M
- Net Income
- -113.70M
- EBITDA
- -154.72M
- Earnings Per Share (EPS)
- -1.28
Cash Flow
In the last 12 months, operating cash flow was -347.36M and capital expenditures -2.44M, giving a free cash flow of -349.80M billion.
- Operating Cash Flow
- -347.36M
- Free Cash Flow
- -349.80M
- Free Cash Flow per Share
- -3.40
Dividends & Yields
IDEAYA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.06%
- Earnings Yield
- -12.47%
Stock Price Statistics
- Beta
- 1.27
- 52-Week Price Change
- 2.20%
- 50-Day Moving Average
- 36.27
- 200-Day Moving Average
- 33.92
- Relative Strength Index (RSI)
- 45.51
- Average Volume (3m)
- 892.49K
Important Dates
IDEAYA Biosciences upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- ―
Financial Position
IDEAYA Biosciences as a current ratio of 11.34, with Debt / Equity ratio of 2.73%
- Current Ratio
- 11.34
- Quick Ratio
- 11.34
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.55
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, IDEAYA Biosciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
IDEAYA Biosciences EV to EBITDA ratio is -6.68, with an EV/FCF ratio of -8.38.
- EV to Sales
- 80.23
- EV to EBITDA
- -6.68
- EV to Free Cash Flow
- -8.38
- EV to Operating Cash Flow
- -8.44
Balance Sheet
IDEAYA Biosciences has $838.54M in cash and marketable securities with $29.70M in debt, giving a net cash position of $808.84M billion.
- Cash & Marketable Securities
- $838.54M
- Total Debt
- $29.70M
- Net Cash
- $808.84M
- Net Cash Per Share
- $8.36
- Tangible Book Value Per Share
- $10.61
Margins
Gross margin is 100.00%, with operating margin of -1267.38%, and net profit margin of -1149.62%.
- Gross Margin
- 100.00%
- Operating Margin
- -1267.38%
- Pretax Margin
- -1149.62%
- Net Profit Margin
- -1149.62%
- EBITDA Margin
- -1200.47%
- EBIT Margin
- -1209.07%
Analyst Forecast
The average price target for IDEAYA Biosciences is $50.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $50.82
- Price Target Upside
- 55.34% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 12
- Revenue Growth Forecast
- -82.99%
- EPS Growth Forecast
- -144.53%
Scores
- Smart Score
- 9
- AI Score
- 47
